88 related articles for article (PubMed ID: 1394210)
1. Isolation of a prostate carcinoma cell proliferation-inhibiting factor from human seminal plasma and its similarity to transforming growth factor beta.
Lokeshwar BL; Block NL
Cancer Res; 1992 Oct; 52(20):5821-5. PubMed ID: 1394210
[TBL] [Abstract][Full Text] [Related]
2. Beta-2 microglobulin is mitogenic to PC-3 prostatic carcinoma cells and antagonistic to transforming growth factor beta 1 action.
Rowley DR; Dang TD; McBride L; Gerdes MJ; Lu B; Larsen M
Cancer Res; 1995 Feb; 55(4):781-6. PubMed ID: 7850789
[TBL] [Abstract][Full Text] [Related]
3. Human prostatic inhibin suppresses tumor growth and inhibits clonogenic cell survival of a model prostatic adenocarcinoma, the Dunning R3327G rat tumor.
Lokeshwar BL; Hurkadli KS; Sheth AR; Block NL
Cancer Res; 1993 Oct; 53(20):4855-9. PubMed ID: 8402673
[TBL] [Abstract][Full Text] [Related]
4. Autonomous growth of androgen-independent human prostatic carcinoma cells: role of transforming growth factor alpha.
Hofer DR; Sherwood ER; Bromberg WD; Mendelsohn J; Lee C; Kozlowski JM
Cancer Res; 1991 Jun; 51(11):2780-5. PubMed ID: 2032218
[TBL] [Abstract][Full Text] [Related]
5. Genetic change in transforming growth factor beta (TGF-beta) receptor type I gene correlates with insensitivity to TGF-beta 1 in human prostate cancer cells.
Kim IY; Ahn HJ; Zelner DJ; Shaw JW; Sensibar JA; Kim JH; Kato M; Lee C
Cancer Res; 1996 Jan; 56(1):44-8. PubMed ID: 8548772
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
Guo Y; Kyprianou N
Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
[TBL] [Abstract][Full Text] [Related]
7. Purification and biological properties of type beta transforming growth factor from mouse transformed cells.
Fernandez-Pol JA; Klos DJ; Grant GA
Cancer Res; 1986 Oct; 46(10):5153-61. PubMed ID: 3489522
[TBL] [Abstract][Full Text] [Related]
8. Modulation of sensitivity to transforming growth factor-beta 1 (TGF-beta 1) and the level of type II TGF-beta receptor in LNCaP cells by dihydrotestosterone.
Kim IY; Zelner DJ; Sensibar JA; Ahn HJ; Park L; Kim JH; Lee C
Exp Cell Res; 1996 Jan; 222(1):103-10. PubMed ID: 8549651
[TBL] [Abstract][Full Text] [Related]
9. The inhibitory effects of gossypol on human prostate cancer cells-PC3 are associated with transforming growth factor beta1 (TGFbeta1) signal transduction pathway.
Jiang J; Sugimoto Y; Liu S; Chang HL; Park KY; Kulp SK; Lin YC
Anticancer Res; 2004; 24(1):91-100. PubMed ID: 15015581
[TBL] [Abstract][Full Text] [Related]
10. Modulation of transforming growth factor beta 1 effects on prostate cancer cell proliferation by growth factors and extracellular matrix.
Morton DM; Barrack ER
Cancer Res; 1995 Jun; 55(12):2596-602. PubMed ID: 7780974
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
Jakowlew SB; Moody TW; Mariano JM
Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
[TBL] [Abstract][Full Text] [Related]
12. Insulin-like growth factor binding protein-2 mediates the inhibition of DNA synthesis by transforming growth factor-beta in mink lung epithelial cells.
Dong F; Wu HB; Hong J; Rechler MM
J Cell Physiol; 2002 Jan; 190(1):63-73. PubMed ID: 11807812
[TBL] [Abstract][Full Text] [Related]
13. Restoration of transforming growth factor beta signaling pathway in human prostate cancer cells suppresses tumorigenicity via induction of caspase-1-mediated apoptosis.
Guo Y; Kyprianou N
Cancer Res; 1999 Mar; 59(6):1366-71. PubMed ID: 10096572
[TBL] [Abstract][Full Text] [Related]
14. Secretion of transforming growth factor-beta isoforms by embryonic stem cells: isoform and latency are dependent on direction of differentiation.
Slager HG; Freund E; Buiting AM; Feijen A; Mummery CL
J Cell Physiol; 1993 Aug; 156(2):247-56. PubMed ID: 8344983
[TBL] [Abstract][Full Text] [Related]
15. Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-alpha in human prostate cancer cells.
Seth D; Shaw K; Jazayeri J; Leedman PJ
Br J Cancer; 1999 May; 80(5-6):657-69. PubMed ID: 10360641
[TBL] [Abstract][Full Text] [Related]
16. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma.
Yang F; Strand DW; Rowley DR
Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743
[TBL] [Abstract][Full Text] [Related]
17. Effect of epidermal growth factor/transforming growth factor alpha and transforming growth factor beta 1 on growth in vitro of rat urinary bladder carcinoma cells.
Kawamata H; Azuma M; Kameyama S; Nan L; Oyasu R
Cell Growth Differ; 1992 Nov; 3(11):819-25. PubMed ID: 1467309
[TBL] [Abstract][Full Text] [Related]
18. Paracrine and autocrine regulation of human melanocyte and melanoma cell growth by transforming growth factor beta in vitro.
Krasagakis K; Garbe C; Schrier PI; Orfanos CE
Anticancer Res; 1994; 14(6B):2565-71. PubMed ID: 7872682
[TBL] [Abstract][Full Text] [Related]
19. Growth factor regulation of gene expression in the human prostatic carcinoma cell line LNCaP.
Henttu P; Vihko P
Cancer Res; 1993 Mar; 53(5):1051-8. PubMed ID: 7679946
[TBL] [Abstract][Full Text] [Related]
20. Tyrosine protein kinase activity of human hyperplastic prostate and carcinoma cell lines PC3 and DU145.
Durocher Y; Chapdelaine A; Chevalier S
Cancer Res; 1989 Sep; 49(17):4818-23. PubMed ID: 2474374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
